Vertex Pharmaceuticals(VRTX) Stock Price Today

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

S&P 500 Exits Q1 in the Red - Here Are Its Largest Losers and Winners
Seeking Alpha17:08 ET
Vertex Discontinues Development Of Type 1 Diabetes Candidate After Disappointing Data
Benzinga15:03 ET
How Peter Marks' FDA Departure Is Impacting Pharma, Biotech Stocks
Seeking Alpha12:37 ET
Vertex Non-opioid Painkiller Journavx Gets Mixed ICER Review
Seeking AlphaMar 31 11:33 ET
Jim Cramer on Vertex Pharmaceuticals (VRTX): "Revolutionary Pain Drug on the Horizon!"
Yahoo FinanceMar 31 09:33 ET
Vertex Pharmaceuticals Is Maintained at Buy by B of A Securities
Dow JonesMar 31 08:05 ET · Ratings

Comments

Teddy123

Jan 31 15:16

Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease in England

$Vertex Pharmaceuticals (VRTX.US)$
Revolutionary Gene Therapy CASGEVY Now Available Through NHS England: Major Win for Sickle Cell Patients

1

Teddy123

Jan 31 13:42

Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain

$Vertex Pharmaceuticals (VRTX.US)$
FDA Approves First Non-Opioid Pain Drug in 20 Years: Vertex's Game-Changing Alternative to Opioids

1

Stock_Drift

Jan 31 09:13

$Vertex Pharmaceuticals (VRTX.US)$

Vertex Pharmaceuticals Jumps On FDA Approval For Non-Opioid Painkiller

1

Lnova

Jan 28 17:25

$Vertex Pharmaceuticals (VRTX.US)$ am watching this one to see the outcome biopharmcatalys...
has options
“Suzetrigine: The FDA has assigned a PDUFA target action date of January 30, 2025, for suzetrigine for the treatment of moderate-to-severe acute pain. Suzetrigine was granted Priority Review by the FDA.
The Non-Opioids Prevent Addiction In the Nation (NOPAIN) Act became effective on January 1st, 2025. The NOPAIN Act mandates that Medicare provide a separate add-on payment in the hospital outp...

Justice Bao

Dec 29, 2024 18:21

$Vertex Pharmaceuticals (VRTX.US)$ long term play

1

VRTX Vertex Pharmaceuticals

Trade Overview

Capital Trend

News

Comments

Market Insights